Pharma Journalist 9027 posts 0 comments

Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, announced final efficacy of 96.4% against mild, moderate and severe disease…
Read More...

PhaseBio Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and BioVectra…
Read More...

Orgenesis Inc. a global biotech company working to unlock the full potential of cell and gene therapies,  announces that it has entered the planned second phase of a collaboration with…
Read More...

Complix, a biopharmaceutical company developing a pipeline of transformative Alphabody therapeutics announces that it has signed a significant drug discovery deal with I-Mab, an…
Read More...

SMi Group Reports: Exclusive interview with Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel International who will be chairing at SMi’s 4th Annual  Microbiology East…
Read More...

CEPI, the Coalition for Epidemic Preparedness Innovations, and VBI Vaccines Inc. announced a partnership to develop VBI’s enveloped virus like particle (eVLP) vaccine candidates against…
Read More...

Enveric Biosciences a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced that it has acquired an…
Read More...

Sparta Biopharma, Inc., a privately-held company, developing osteobiologics for sports medicine announces the availability of BioEnthesis, the first-of-its-kind allograft that has both…
Read More...

NeuroRx, Inc. and TFF Pharmaceuticals, Inc. are announcing that the companies have entered into a feasibility and material transfer agreement (Feasibility Agreement). Under the…
Read More...

Novartis announced the Phase III CANOPY-2 study evaluating canakinumab (ACZ885), an inhibitor of interleukin-1beta (IL-1β), in combination with the chemotherapy agent docetaxel, did not…
Read More...